ORADUR-Methylphenidate

methylphenidate · Orient Pharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ORADUR-Methylphenidate, covering 2021-12-06 to 2021-12-15. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate Long-term Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD [Phase 3]